Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Clarke, JM; Pang, H; Starr, MD; Hatch, AJ; Kindler, HL; O'Reilly, EM; Innocenti, F; Venook, AP; Hurwitz, H; Nixon, AB

Published Date

  • January 20, 2015

Published In

Volume / Issue

  • 33 / 3_suppl

Start / End Page

  • 306 - 306

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2015.33.3_suppl.306